41
TaiMed Bio
4147.TW·TWSETaipei TWFounded 2007100 employees
Small CapbiotechPublicInfectious Disease
Platform: Ibalizumab HIV
Market Cap
$0.3B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (4147.TW)
Loading 4147.TW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 414-2764 | 414-2764 | Phase 2/3 | 1 | Tau | MyelofibrosisPompe | ||
| 414-5700 | 414-5700 | Preclinical | 2 | USP1 | MM |
SEC Filings & Financial Documents
SEC filings are not available for TWSE-listed companies.
TaiMed Bio trades on TWSE (TW). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)